Chung Te Chang

US Patent:

6637002, Oct 21, 2003

Filed:

Oct 21, 1998

Appl. No.:

09/176658

Inventors:

Shih Mo - Milpitas CA
Chung Chang - San Jose CA

Assignee:

Maxtor Corporation - Longmont CO

International Classification:

H03M 1300

US Classification:

714781, 708507

Abstract:

A decoder for decoding block error correction codes is described. The decoder includes a first search circuit to find roots of an error location polynomial corresponding to an error location and a second search circuit to find roots of an error location polynomial corresponding to an error location. A multiplexer is fed by the first search circuit and the second search circuit to produce an error location from the error location polynomial.

US Patent:

6820095, Nov 16, 2004

Filed:

Apr 16, 2001

Appl. No.:

09/834658

Inventors:

Sofia Yeung - Union City CA
Chung Chang - San Jose CA

Assignee:

Oracle International Corporation - Redwood Shores CA

International Classification:

G06F 1730

US Classification:

707200, 707205, 711173

Abstract:

An object, such as a relational database table, is partitioned into a plurality of subsets. Selected subsets, e. g. partitions, of the object are exported into a dump file, identifying each exported subset of data by writing a marker in the dump file. Selected subsets are imported from the dump file, by determining whether the marker in the dump file corresponds to the selected subsets, then conditionally importing the data associated with the marker. Objects are repartitioned by exporting the some of the subsets, reconfiguring the object, and importing the exported subsets back into the object.

US Patent:

7020282, Mar 28, 2006

Filed:

Sep 5, 2000

Appl. No.:

09/655230

Inventors:

Chung Nan Chang - Los Altos CA, US

International Classification:

H04L 9/00
H04K 1/00

US Classification:

380 44, 380 28, 380 30, 380285, 713171

Abstract:

One aspect of the present invention establishes a session key by a receiving unit R transmitting a plurality of quantities for storage in a public repository. A sending unit S:Another aspect provides a digital signature. Before transmitting a signed message, the unit S stores a plurality of quantities in the public repository. A unit R, that receives the message and the digital signature, verifies their authenticity by:.

US Patent:

7327846, Feb 5, 2008

Filed:

Sep 5, 2000

Appl. No.:

09/655229

Inventors:

Chung Nan Chang - Los Altos CA, US

International Classification:

H04L 9/00
H04K 1/00

US Classification:

380285, 380277, 380282, 380259, 713171

Abstract:

One aspect of the present invention establishes a session key by a receiving unit R transmitting a plurality of quantities for storage in a public repository. A sending unit S:Another aspect provides a digital signature. Before transmitting a signed message, the unit S stores a plurality of quantities in the public-repository. A unit R, that receives the message and the digital signature, verifies their authenticity by:.

US Patent:

7604800, Oct 20, 2009

Filed:

May 10, 2005

Appl. No.:

11/125837

Inventors:

Rong-Hwa Lin - Taipei, TW
Chung Nan Chang - Foster City CA, US
Pei-Jiun Chen - Taipei, TW
Chiu-Chen Huang - Taipei, TW

Assignee:

AbGenomics Coöperatief U.A. - Amsterdam

International Classification:

A61K 39/395
C07K 16/28

US Classification:

4241541, 4241301, 4241331, 4241411, 4241431, 4241441, 4241521, 4241531, 4241721, 4241731, 5303871, 5303873, 5303881, 5303882, 53038822, 5303887, 53038873, 53038875

Abstract:

Immunoglobulin chains or antibodies having light or heavy chain complementarity determining regions of antibodies that bind to P-Selectin Glycoprotein Ligand-1. Also disclosed are methods of inducing death of an activated T-cell and of modulating a T cell-mediated immune response in a subject.

US Patent:

8287871, Oct 16, 2012

Filed:

Mar 6, 2009

Appl. No.:

12/399484

Inventors:

Rong-Hwa Lin - Taipei, TW
Chung Nan Chang - Foster City CA, US
Pei-Jiun Chen - Taipei, TW
Chiu-Chen Huang - Taipei, TW

Assignee:

AbGenomics Cooperatief U.A. - Amsterdam

International Classification:

A61K 39/395
C07K 16/28

US Classification:

4241541, 4241301, 4241331, 4241411, 4241431, 4241441, 4241521, 4241531, 4241721, 4241731, 5303871, 5303873, 5303881, 5303882, 53038822, 5303887, 53038873, 53038875

Abstract:

Immunoglobulin chains or antibodies having light or heavy chain complementarity determining regions of antibodies that bind to P-Selectin Glycoprotein Ligand-1. Also disclosed are methods of inducing death of an activated T-cell and of modulating a T cell-mediated immune response in a subject.

US Patent:

8361472, Jan 29, 2013

Filed:

Aug 17, 2010

Appl. No.:

12/858110

Inventors:

Chung Nan Chang - Foster City CA, US
Pei-Jiun Chen - Taipei, TW
Chiu-Chen Huang - Taipei, TW

Assignee:

AbGenomics Cooperatief U.A. - Amsterdam

International Classification:

A61K 39/395
C07K 16/28

US Classification:

4241541, 4241301, 4241331, 4241411, 4241431, 4241441, 4241521, 4241531, 4241721, 4241731, 5303871, 5303873, 5303881, 5303882, 53038822, 5303887, 53038873, 53038875

Abstract:

Immunoglobulin chains or antibodies having light or heavy chain complementarity determining regions of antibodies that bind to P-Selectin Glycoprotein Ligand-1. Also disclosed are methods of inducing death of an activated T-cell and of modulating a T cell-mediated immune response in a subject.

US Patent:

8628775, Jan 14, 2014

Filed:

Sep 18, 2009

Appl. No.:

12/562515

Inventors:

Chung Nan Chang - Foster City CA, US

Assignee:

AbGenomics Cooperatief U.A. - Cm Amsterdam Zuidoost

International Classification:

A61K 38/17
C07K 14/435

US Classification:

4241341, 4241921, 514 122, 514 209, 530350, 5303873

Abstract:

Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods of the invention can be used to control unwanted T cell- or NK cell-mediated immune responses in conditions such as inflammatory diseases, autoimmune diseases, transplant rejection, and allergic diseases.